ID   VK [Human embryonal rhabdomyosarcoma]
AC   CVCL_Y578
SY   Urumov-1
DR   Wikidata; Q54993188
RX   PubMed=1322234;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Doubling time: 38 hours (PubMed=1322234).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
RX   PubMed=1322234; DOI=10.1016/0165-4608(92)90092-M;
RA   Urumov I.J., Manolova Y.;
RT   "Cytogenetic analysis of an embryonal rhabdomyosarcoma cell line.";
RL   Cancer Genet. Cytogenet. 61:214-215(1992).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//